A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial Group. (Record no. 7639402)

MARC details
000 -LEADER
fixed length control field 01600 a2200481 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513034854.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199509s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0269-9370
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Jablonowski, H
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19950915
245 00 - TITLE STATEMENT
Title A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial Group.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. AIDS (London, England)
Date of publication, distribution, etc. May 1995
300 ## - PHYSICAL DESCRIPTION
Extent 463-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element AIDS-Related Complex
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Acquired Immunodeficiency Syndrome
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element CD4 Lymphocyte Count
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Didanosine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Progression
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Evaluation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Tolerance
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pancreatitis
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Zidovudine
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arasteh, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Staszewski, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ruf, B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stellbrink, H J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schrappe, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stoehr, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Haase, W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schomaker, U
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name von Eisenhart Rothe, B
773 0# - HOST ITEM ENTRY
Title AIDS (London, England)
Related parts vol. 9
-- no. 5
-- p. 463-9

No items available.